Skip to content

Clinical trials

Peripheral Vascular Diseases trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Vascular Diseases Phase: Not applicable Clear all

165 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20022
20032
20042
20051
20066
20079
20086
20094
201010
20117
20125
201310
20149
20158
201610
20175
20189
20197
20206
20216
20226
202310
20249
20257
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed99
Unknown status24
Terminated19
Recruiting10
Withdrawn5
Not yet recruiting4
Active, not recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices8
Cook Group Incorporated6
Chengdu University of Traditional Chinese Medicine5
Imperial College London5
Medtronic Endovascular5
C. R. Bard4
Northwestern University4
Medical College of Wisconsin3
Stanford University3
University of Washington3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Vascular Diseases165
Peripheral Arterial Disease65
Intermittent Claudication24
Chronic Limb-Threatening Ischemia12
Atherosclerosis11
Cardiovascular Diseases11
Arterial Occlusive Diseases9
Diabetes Mellitus6
Vascular Diseases6
Diabetes Mellitus, Type 25

Trials

Showing 26 to 50 of 165. Each trial links to its page on Pharma Observatory.

65 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.